
The April 2005 issue of
Sweet & Maxwell's monthly
European Intellectual Property Review has now been published. This issue leads with an opinion by Colin Davies on access by developing countries to patented medicines in the post-
Glaxo v Dowelhurst and
Doha era. There's also a lengthy review of Community trade mark decisions from Alicante and Luxembourg during 2004 from Arnaud Folliard-Monguiral (OHIM IP Litigation Unit) and David Rogers (European Commission).